Thyroid Cancer Drugs Global Market Research Report 2022: Focus on Ipilimumab, Cabozantinib-S-Malate, Caprelsa (Vandetanib), Doxorubicin Hydrochloride, Lenvatinib Mesylate, Nivolumab, Vandetanib – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Thyroid Cancer Drugs Global Market Report 2022, Drug Type, End Users, Type” report has been added to ResearchAndMarkets.com’s offering. The global thyroid cancer drugs market is expected to grow from $0.61 billion in 2021 to $0.72 billion in 2022 at a compound annual growth rate (CAGR) of 18.6%. The market is expected to … [Read more…]
